Patent Assignment
Reel/Frame 061119/0681
Security Interest
Recorded: 2022-09-16
Pages: 15
Assignor
ATHENEX, INC.
Executed: 2022-08-01
Assignee
SAGARD HEALTHCARE ROYALTY PARTNERS, LP, AS ADMINISTRATIVE AGENT
161 BAY STREET, SUITE 5000, TORONTO, M5J 2S1, CANADA
Covered Properties
(40)
Compositions for of Treating Cell Proliferation Disorders
Compositions and Methods of Treating Cell Proliferation Disorders
Compositions and Methods of Treating Cell Proliferation Disorders
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Biaryl Compositions in Combination with Tamoxifen and Methods for Modulating a Kinase Cascade
Application:
17/462,155 →
Publication:
US 2022/0119347
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Application:
17/151,835 →
Publication:
US 2021/0252008
Compositions and Methods of Treating Cell Proliferation Disorders
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Anti-cancer compounds and methods of use thereof
Application:
60/639,834 →
Kinase inhibitors
Application:
60/704,551 →
Compositions and methods of treating cell proliferation disorders
Application:
60/727,341 →
Biaryl compositions and methods for modulating a kinase cascade
Application:
60/923,496 →
Biaryl Compositions and Methods for Modulating a Kinase Cascade
Composition and Methods for Modulating a Kinase Cascade
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Application:
17/203,867 →
Publication:
US 2021/0198202
Composition and methods for modulating a kinase cascade
Application:
60/877,762 →
Process for the Preparation of Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Pharmaceutical Compositions for Modulating a Kinase Cascade and Methods of Use Thereof
Application:
17/488,433 →
Publication:
US 2022/0160672
Clinical assessment of KX2-391
Application:
60/999,943 →
Compositions and Methods for the Prevention and Treatment of Cancer
Methods for the Prevention and Treatment of Cancer Using Biaryl Compounds
Application:
61/324,866 →
Methods of Treating and/or Preventing Actinic Keratosis
Methods of Treating and/or Preventing Actinic Keratosis
Methods of Treating and/or Preventing Actinic Keratosis
Application:
62/469,889 →
Methods of Treating and/or Preventing Psoriasis
Application:
17/616,238 →
Publication:
US 2022/0305021
Methods of Treating and/or Preventing Psoriasis
Application:
62/857,796 →
Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)Phenyl)Pyridin-2-Yl)-N-Benzylacetamide
Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)Phenyl)Pyridin-2-Yl)-N-Benzylacetamide
Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)Phenyl)Pyridin-2-Yl)-N-Benzylacetamide
Solid Forms of 2-(5-(4-(2-Morpholinoethoxy)Phenyl)Pyridin-2-Yl)-N-Benzylacetamide
Application:
62/555,390 →
Compositions and Methods for Treating Hyperproliferative Skin Disorders
Compositions and Methods for Treating Hyperproliferative Skin Disorders
Application:
62/639,742 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 7, 2006
From: HANGAUER, JR., DAVID G.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 017614/0304 →
Assignment of Assignor's Interest
Aug 24, 2006
From: HANGAUER, JR., DAVID G.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 018163/0711 →
Assignment of Assignor's Interest
May 16, 2008
From: HANGAUER, DAVID G., JR.; COUGHLIN, DANIEL; CODY, JEREMY A.; GALE, JONATHAN
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 020956/0795 →
Assignment of Assignor's Interest
Jul 7, 2009
From: PATRA, DEBASIS
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 022920/0524 →
Corrective Assignment to Correct the Assignee Address to 701 Ellicott Street, Ny Center for Excellence in Bioinformatics and Life Sciences, Buffalo, Ny 14203 Previously Recorded on Reel 022920 Frame 0524. Assignor(S) Hereby Confirms the Debasis Patra to Kinex Pharmaceuticals, Llc.
Jul 14, 2009
From: PATRA, DEBASIS
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 022950/0363 →
Assignment of Assignor's Interest
Apr 30, 2010
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 024315/0763 →
Assignment of Assignor's Interest
Mar 22, 2011
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 026001/0128 →
Assignment of Assignor's Interest
Mar 22, 2011
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 025997/0092 →
Assignment of Assignor's Interest
May 3, 2011
From: HANGAUER, DAVID G., JR.; PATRA, DEBASIS; CODY, JEREMY A.; PALMER, GRANT J.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 026218/0635 →
Assignment of Assignor's Interest
May 3, 2011
From: PATRA, DEBASIS; PALMER, GRANT J.; ISBESTER, PAUL K.; SALSBURY, JONATHON
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 026218/0569 →
Assignment of Assignor's Interest
May 3, 2011
From: HANGAUER, DAVID G., JR.; COUGHLIN, DANIEL; CODY, JEREMY A.; GALE, JONATHAN
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 026218/0608 →
Assignment of Assignor's Interest
May 15, 2012
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 028208/0523 →
Assignment of Assignor's Interest
Oct 2, 2012
From: HANGAUER, DAVID G., JR.; PATRA, DEBASIS; CODY, JEREMY A.; PALMER, GRANT J.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 029063/0654 →
Assignment of Assignor's Interest
Jul 25, 2013
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 030874/0034 →
Confirmatory License
Mar 31, 2014
From: UNIVERSITY OF KANSAS LAWRENCE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 032568/0507 →
Assignment of Assignor's Interest
Sep 9, 2014
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 033701/0873 →
Assignment of Assignor's Interest
Sep 15, 2014
From: HANGAUER, DAVID G., JR.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 033736/0684 →
Confirmatory License
Feb 24, 2015
From: UNIVERSITY OF KANSAS LAWRENCE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 035072/0377 →
Assignment of Assignor's Interest
Aug 11, 2015
From: HANGAUER, DAVID G., JR
To: KINEX PHARMACEUTICALS, INC.
Reel/Frame 036301/0040 →
Assignment of Assignor's Interest
Sep 8, 2015
From: HANGAUER, DAVID G., JR.; PATRA, DEBASIS; CODY, JEREMY A.; PALMER, GRANT J.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 036512/0077 →
Change of Name
Sep 10, 2015
From: KINEX PHARMACEUTICALS, LLC
To: KINEX PHARMACEUTICALS, INC.
Reel/Frame 036585/0786 →
Change of Name
Sep 21, 2015
From: KINEX PHARMACEUTICALS, INC.
To: ATHENEX, INC.
Reel/Frame 036644/0296 →
Assignment of Assignor's Interest
Oct 30, 2015
From: HANGAUER, DAVID G., JR.; PATRA, DEBASIS; CODY, JEREMY A.; PALMER, GRANT J.
To: KINEX PHARMACEUTICALS, LLC
Reel/Frame 036923/0218 →
Patent Security Agreement
Jul 3, 2018
From: ATHENEX, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 047247/0812 →
Release of Security Interest
Jun 19, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: ATHENEX, INC.
Reel/Frame 052990/0677 →